NGeneBio Co., Ltd. (KOSDAQ:354200)

NGeneBio Revenue

NGeneBio had revenue of 11.95B KRW in the quarter ending March 31, 2026, with 500.13% growth. This brings the company's revenue in the last twelve months to 31.20B, up 363.66% year-over-year. In the year 2025, NGeneBio had annual revenue of 21.24B with 278.54% growth.

• Revenue (ttm): 31.20B
• Revenue Growth: +363.66%
• P/S Ratio: 0.79
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 24.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	21.24B	15.63B	278.54%
Dec 31, 2024	5.61B	1.26B	28.96%
Dec 31, 2023	4.35B	-6.67B	-60.51%
Dec 31, 2022	11.02B	3.85B	53.81%
Dec 31, 2021	7.16B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error